- About About
-
Medical
Medical
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
-
-
Michael Teague Is Free at Last, as Federal Judge Questions Another Federal Medical Marijuana Prosecution
Yesterday, U.S. District Court Judge David Carter terminated the supervised release of Michael Teague fifteen months early in response to a motion filed by Americans for Safe Access. Michael was one of the first federal medical marijuana prosecutions in California. He served nearly seventeen months in federal prison, and a month and a half in a halfway house, before serving almost 33 months of a four-year term of supervised release for cultivating 102 plants. In cutting Michael loose early from the onerous drug-testing and other conditions of supervised release, Judge Carter commented on Michael's exemplary conduct.
What made the hearing interesting, though, is that Judge Carter went to lengths to explain that it was tragic for Michael to have been harmed so severely for being caught in the conflict between state and federal law. Through these statements, Judge Carter joins Judge Breyer of the Rosenthal case as federal judges who have openly criticized or questioned federal criminal prosecutions of medical marijuana patients.
Share